期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

努力提高脑胶质瘤的诊治水平 被引量：1

原文传递
导出
摘要 脑胶质瘤是神经外科常见的颅内肿瘤，约占颅内肿瘤的45％--50％，恶性程度高，呈弥漫、浸润性生长，手术易复发，治疗效果差。随着现代影像学技术的发展如CT、核磁共振技术，128层CT灌注技术、PET—CT等技术的发展，一般认为其易诊断，但目前有关该方面治疗需要注意如下几个方面。
作者 刘福生
机构地区 首都医科大学附属北京天坛医院神经外科中心 北京市神经外科研究所脑肿瘤研究中心
出处 《中华临床医师杂志（电子版）》 CAS 2013年第14期8-9,共2页 Chinese Journal of Clinicians(Electronic Edition)
关键词 脑胶质瘤 现代影像学技术 治水 核磁共振技术 颅内肿瘤 治疗效果 浸润性生长 神经外科
分类号 R739.4 [医药卫生—肿瘤]
  • 相关文献

参考文献16

  • 1Wen PY,Kesari S. Malignant gliomas in adults[J].New England Journal of Medicine,2008,(5):492-507.doi:10.1056/NEJMra0708126.
  • 2Louis DN,Ohgaki H,Wiestler OD. The 2007 WHO classification of tumours of the central nervous system[J].Acta Neuropathologica,2007.97-109.
  • 3Sekhar LN,Chanda A,Morita A. The preservation and reconstruction of cerebral veins and sinuses[J].Journal of Clinical Neuroscience,2002.391-399.
  • 4Sakata K,Al-Mefty O,Yamamoto I. Venous consideration in petrosal approach:microsurgical anatomy of the temporal bridging vein[J].Neurosurgery,2000.153-160.
  • 5朱镛连.大脑两半球的解剖、功能与障碍[J].中国康复理论与实践,2011,17(6):598-600. 被引量：5
  • 6王忠诚.王忠诚神经外科学[M]武汉:湖北科学技术出版社,2005928-930.
  • 7杨军,马林.高分级胶质瘤的放化综合治疗[J].中华放射肿瘤学杂志,2006,15(2):100-103. 被引量：16
  • 8蒋马伟,周仁华,姚原,林青,夏士安,吴国华.脑胶质瘤放疗靶区确定的方法学研究[J].中华肿瘤防治杂志,2007,14(13):997-999. 被引量：8
  • 9江涛;刘福生.脑胶质瘤[M]北京:人民卫生出版社,2006210-217.
  • 10Hegi ME,Diserens AC,Godard S. Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide[J].Clinical Cancer Research,2004.1871-1874.

二级参考文献90

  • 1DeAngelis LM. Brain tumors[J]. N Engl J Med, 2001, 344 (2):114-123.
  • 2Buckner JC. Factors influencing survival in high-grade gliomas[J]. Semin Oncol, 2003, 30(6 Suppl 19):10-14.
  • 3Curran WJ Jr, Scott CB, Horton J, et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials[J]. J Natl Cancer Inst, 1993, 85(9):704-710.
  • 4Stewart LA. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials [J]. Lancet, 2002, 359 (9311):1011-1018.
  • 5ReifenbergerG, Louis DN. Oligodendroglioma: toward molecular definitions in diagnostic neuro-oncology [J]. J Neuropathol Exp Neurol, 2003, 62(2):111-126.
  • 6Cairncross JG, Macdonald DR. Successful chemotherapy for recurrent malignant oligodendroglioma[J]. Ann Neurol, 1988, 23(4):360-364.
  • 7van den Bent M J, Carpentier AF, Brandes AA, et al. Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase Ⅲ trial[J]. J Clin Oncol, 2006, 24(18): 2715-2722.
  • 8Intergroup Radiotion Therapy Oncology Group Trial 9402, Cairncross G, Berkey B, et al. Phase Ⅲ trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Ontology Group Trial 9402[J]. J Clin Oncol, 2006, 24(18): 2707-2714.
  • 9Hildebrand J, Sahmoud T, Mignolet F, et al. Adjuvant therapy with dibromodulcitol and BCNU increases survival of adults with malignant gliomas. EORTC Brain Tumor Group[J]. Neurology, 1994, 44(6):1479-1483.
  • 10Medical Research Council Brain Tumor Working Party. Randomized trial of procarbazine, lomustine and vincristine in the adjuvant treatment of high-grade astrocytoma: a Medical Research Council trial[J]. J Clin Oncol, 2001, 19(2): 509-518.

共引文献29

同被引文献44

  • 1中国防治认知功能障碍专家共识专家组.中国防治认知功能障碍专家共识[J].神经病学与神经康复学杂志,2006(2):98-100. 被引量：44
  • 2Tosoni A, Franeeschi E, Ermani M, et al. Emozolomide three weeks on and one week off as first line therapy for patients with recurrent or progressive low grade gliomas[J]. J Neurooncol,2008,89(2) :179-185.
  • 3Tang Y, Luo D, Rong X, et al. Psychological disorders, cognitive dysfunction and quality of life in nasopharyngeal carcinoma patients with radiation-induced brain injury[J].PLoS One, 2012,7(6) :e36529.
  • 4Louis D N,Ohgaki H,Wiestler O D, et al. The 2007 WHO classification of tumours of the central nervous system[J]. Aeta Neuropathol,2007,114(2) :97-109.
  • 5Posti J P,Bori M,Kauko T,et al. Presenting symptoms of glioma in adults[J]. Acta Neurol Seand,2015,131(2) : 88-93.
  • 6Steno A, Mate j c ik V, Stefio J. Intraoperative ultrasound in low-grade glioma surgery [J]. Clin Neurol Neurosurg, 2015, 135 : 96-99.
  • 7Xu H, Ding S, Hu X, et al. Reduced efficiency of functional brain network underlying intellectual decline in patients with low-grade glioma[J]. Neurosci Lett, 2013,543 : 27-31.
  • 8Luechiari C, Botturi A, Silvani A, et al. Cognitive strategies and quality of life of patients with high-grade glioma[J]. Support Care Cancer,2015,23(12):3427-3435.
  • 9Alomar S A. Clinical manifestation of central nervous system tumor[J]. Semin Diagn Pathol, 2010,27(2) : 97-104.
  • 10Giovagnoli A R. Investigation of cognitive impairments in people with brain tumors[J]. J Neurooncol, 2012,108 (2) 277-283.

引证文献1

二级引证文献3

中华临床医师杂志（电子版）
2013年 第14期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部